Skip to main content
Email Print Share

News From the Field

Rett syndrome drug shows promise in clinical trial


June 23, 2014

This material is available primarily for archival purposes. Telephone numbers or other contact information may be out of date; please see current contact information at media contacts.

Massachusetts Institute of Technology (MIT) scientists first identified IGF1 as a possible treatment for Rett syndrome--a rare genetic disorder that causes intellectual disabilities, autism, and physical deformities, has no cure--in 2009, and children who received the drug for four weeks showed improvement in some areas. Now, MIT neuroscientists report some of the molecular detail behind the mechanism of IGF1 action. Full Story

Source
Massachusetts Institute of Technology

The National Science Foundation (NSF) is an independent federal agency that supports fundamental research and education across all fields of science and engineering. In fiscal year (FY) 2017, its budget is $7.5 billion. NSF funds reach all 50 states through grants to nearly 2,000 colleges, universities and other institutions. Each year, NSF receives more than 48,000 competitive proposals for funding and makes about 12,000 new funding awards.

mail icon Get News Updates by Email 

Useful NSF Web Sites:
NSF Home Page: https://www.nsf.gov
NSF News: https://www.nsf.gov/news/
For the News Media: https://www.nsf.gov/news/newsroom.jsp
Science and Engineering Statistics: https://www.nsf.gov/statistics/
Awards Searches: https://www.nsf.gov/awardsearch/